… ration events in patients with open-angle glaucoma (OAG) by … The 516 eligible patients were
randomized to latanoprost or … , the UKGTS is the first randomized, placebo-controlled trial to …

… In the UKGTS, treatment with latanoprost halved VF deterioration risk. Bilateral … Glaucoma
Treatment Study (UKGTS) is the first randomized, double-masked, placebo-controlled trial to …

… study were the investigator-masked, randomized, controlled design and use of latanoprost
… Latanoprost has a well-established efficacy and safety profile, being the first of the currently …

This multicenter retrospective cohort study compared the effectiveness and safety of long-…
latanoprost in patients with primary open-angle glaucoma (POAG) or normal-tension glaucoma …

… least it was double masked and placebo controlled. This was … trial which compared current
first line treatment, Latanoprost to … UKGTS used many of the best aspects of the design of the …

… clinical trials reported a greater reduction in IOP in patients with open-angle glaucoma (OAG) …
% compared with either travoprost 0.004% or latanoprost 0.005% in some instances. Other …

… from ocular hypertension to primary open angle glaucoma and what risk factors influence the
… for moderate to advanced glaucoma. In the UKGTS treatment with latanoprost reduced the …

… assessed the effect of intraocular- lowering treatment with latanoprost on vision preservation
in patients with newly diagnosed open- angle glaucoma. This was the first specific study of …

… that for latanoprost (LT). The aim of the present study was to compare the effectiveness and
safety of an evening dose of TV compared with that of LT in treating open‑angle glaucoma. …

… The UKGTS is the only glaucoma trial to assess the vision-… ) in the latanoprost group (Fig
S1A; for original UKGTS data, see … by latanoprost on the primary outcome, progressive VF loss. …